Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2024, Catalyst Pharmaceutical (CPRX) reported revenue of $128.7 million, up 25.3% over the same period last year. EPS came in at $0.57, compared to -$0.24 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $122.97 million, representing a surprise of +4.65%. The company delivered an EPS surprise of +16.33%, with the consensus EPS estimate being $0.49.While investors closely watch year-over-year changes in headline numbers -- revenue and ea ...